Private investing through venture capital vehicles is an important driver of the US economy and the source of much innovation. The start to 2022 for the industry is mixed because while fundraising, and investing in firms, appears strong, many recent exits don’t look so good, which may clog up the back end of the cycle. About 200 financings of $100 million or more were announced in the first quarter, but deal size and valuation for late-stage companies declined, likely reflecting the complete evaporation of IPOs and a decline in M & A activity. Investors begin to worry about their exits in late-stage firms. Fundraising appeared strong, with $70B in new fund commitments announced, but much of this reflects activity that actually occurred last year, with closings just now being finalized. Fundraising is likely to slow as exits slow. (NVCA Report)
Venture Capital Has a Mixed Start to 2022
By Kevin RocheApril 8, 2022Commentary
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
For those who would like to read more on the crisis of fake and bad science, read this excellent report from the National Association of Scholars. just click this post.
June 4, 2023
CVS has finalized its $10.6 billion buyout of Oak Street health, which operates primary care centers for Medicare members. People may think CVS is a drug store company, but it...
May 4, 2023
Option Care, a large home health care provider is acquiring Amedisys, another large player in that market, for $3.6 billion, as consolidation ramps up across health care, likely meaning higher...
May 4, 2023
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace
June 6, 2023
High Cost Patients in the US Population
A timely new report on the concentration of spending across the entire US population.
June 5, 2023
Help, I’m Melting, I’m Melting…..Not
Antarctica is gaining ice shelf extent and ice mass, not melting and raising sea levels.
June 5, 2023
High Cost Medical Patients
A glimpse at high-cost enrollees in a commercial health plan is revealing.